A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Solution in Subjects With Common Warts.
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Acronyms WART-201
- Sponsors Aclaris Therapeutics
- 13 Dec 2016 Status changed from active, no longer recruiting to completed.
- 01 Dec 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2016.
- 01 Dec 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2016.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History